Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
None listed
Sponsors
IOE, BHU
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to participate in the study. 2. Patients of either sex with ages between 18-60 years. 3. Patients having Hypertension between the time intervals of 6 months to 1 year. 4. Patients suffering from Stage I Hypertension (Systolic Blood Pressure 140-159mm of Hg, Diastolic Blood Pressure 90-99mm of Hg) 5. Patients suffering from Stage I Hypertension are those who are on allopathic medicines. 6. Patients suffering from Isolated Systolic Hypertension.
Exclusion criteria
Exclusion criteria: 1. Patients not willing to participate in the study. 2. Patients of either sex below 18 years & above 60 years will be excluded from the study. 3. Patients having Hypertension for 1 year will be excluded. 4. Patients of Stage II Hypertension (Systolic Blood Pressure >160mmHg and Diastolic Blood Pressure >100mmHg) 5. Patients suffering from serious comorbidities like renal failure, coronary artery disease, Type 2 Diabetes Mellitus, cervical spondylosis, taking medications/drugs (oral contraceptives, steroids, chronic use of NSAIDs etc.). 6. Alcoholics and/or drug abusers. 7. History of hypersensitivity to the trial drug or any of its ingredients. 8. Pregnant/ lactating woman. 9. Patients who have completed participation in any other clinical trial during the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Normalization of Blood Pressure within one month of interventionTimepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce Stress Sound sleep Reduce Palpitations Timepoint: 1 week | — |
Countries
India
Contacts
Public ContactSanjeev Kumar
Institute of Medical Sciences, BHU
Outcome results
None listed